Cargando…
Antibody-mediated immunity to SARS-CoV-2 spike
Despite effective spike-based vaccines and monoclonal antibodies, the SARS-CoV-2 pandemic continues more than two and a half years post-onset. Relentless investigation has outlined a causative dynamic between host-derived antibodies and reciprocal viral subversion. Integration of this paradigm into...
Autores principales: | Errico, John M., Adams, Lucas J., Fremont, Daved H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393763/ https://www.ncbi.nlm.nih.gov/pubmed/36038194 http://dx.doi.org/10.1016/bs.ai.2022.07.001 |
Ejemplares similares
-
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
por: Liu, Zhuoming, et al.
Publicado: (2021) -
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021) -
Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
por: Smith, Brittany K., et al.
Publicado: (2021) -
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura A., et al.
Publicado: (2022) -
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
por: Wrobel, Antoni G., et al.
Publicado: (2020)